← back to search

Debra Van Egeren

Palo Alto University · US
Area of research
Modeling and Simulation · Infectious Diseases
Research interest
Research interests include Medicine, Pandemic, Intensive care medicine, Immune system, Transmission (telecommunications), and Public health.
h-index
citations
1,101
works
13
NIH funding
primary concept
email

Recent publications

Looking under the lamp-post: quantifying the performance of contact tracing in the United States during the SARS-CoV-2 pandemic
BMC Public Health 2024cited by 4position: middledoi
Abstract 4310: Impact of drug combination schedules on the evolution of tumor resistance
Cancer Research 2024cited by 0position: middledoi
Abstract 6904: Model-derived progression-free survival (mPFS): A better metric for patient-derived xenograft studies
Cancer Research 2024cited by 0position: middledoi
Abstract 7378: Using game theory to investigate the therapeutic potential of disrupting tumor-microenvironment interactions
Cancer Research 2024cited by 0position: firstdoi
Abstract 3872: Multi-ancestral origins of colorectal lesionsMulti-ancestral origins of colorectal lesions
Cancer Research 2024cited by 0position: middledoi
Abstract 7182: Blood brain barrier masks effects of dosing strategy
Cancer Research 2024cited by 0position: middledoi
Abstract 4761: Understanding three-drug combinations: optimizing scheduling while avoiding toxicity
Cancer Research 2024cited by 0position: middledoi
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2
Vaccines 2023cited by 23position: firstdoi
Looking under the lamp-post: quantifying the performance of contact tracing in the United States during the SARS-CoV-2 pandemic
medRxiv 2023cited by 0position: middledoi
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis
Scientific Reports 2022cited by 20position: firstdoi
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
PLoS ONE 2021cited by 95position: firstdoi
Individually optimal choices can be collectively disastrous in COVID-19 disease control
BMC Public Health 2021cited by 22position: middledoi
Structure-based programming of lymph-node targeting in molecular vaccines
Nature 2014cited by 937position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 10 papers (2021–2024) · 10 papers (2021–2024)Andrew Chen · Columbia University5 papers (2024–2024) · 3 papers (2024–2024)Laura F. White · Boston University3 papers (2023–2024)Diane Joseph‐McCarthy · Boston University2 papers (2021–2023)Natasha S. Hochberg · Boston University2 papers (2021–2023)Henry Bayly · Boston University2 papers (2023–2024)Michael S. Rogers · Boston Children's Hospital2 papers (2021–2023)Eleanor J. Murray · Boston University2 papers (2023–2024)Bruce R. Zetter · University of Michigan–Ann Arbor2 papers (2021–2023)Aziz Khan · University of Electronic Science and Technology of China1 papers (2024–2024)Clara Park · Massachusetts Institute of Technology1 papers (2014–2014)Aaron M. Horning · Palo Alto University1 papers (2024–2024)William J. Greenleaf · Stanford Medicine1 papers (2024–2024) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Darrell J. Irvine · Scripps Research Institute1 papers (2014–2014)Yiran Zheng · Massachusetts Institute of Technology1 papers (2014–2014)